LUNG TRANSPLANT FAILURE AND REJECTION
Clinical trials for LUNG TRANSPLANT FAILURE AND REJECTION explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT FAILURE AND REJECTION trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT FAILURE AND REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled drug shows promise for lung transplant rejection in small trial
Disease control CompletedThis study tested an inhaled form of cyclosporine A (a drug that calms the immune system) added to standard care for people who had a single lung transplant and developed chronic rejection (bronchiolitis obliterans). The goal was to see if it could slow the decline in lung functi…
Matched conditions: LUNG TRANSPLANT FAILURE AND REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
Inhaled drug shows promise for lung transplant rejection in phase 3 trial
Disease control CompletedThis study tested whether adding an inhaled form of cyclosporine A (L-CsA) to standard treatment helps people who have chronic lung rejection after a double lung transplant. The trial included 169 adults who had their transplant at least a year earlier. The main goal was to see i…
Matched conditions: LUNG TRANSPLANT FAILURE AND REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 18, 2026 12:07 UTC